← Back to guidelines
Cardiology1 paper

Isolated focal cortical dysplasia

Last edited: 4 h ago

Overview

Isolated focal cortical dysplasia (FCD) Type IIa is a malformation of cortical development characterized by neuronal disorganization and balloon cells, often leading to focal epilepsy that may require surgical intervention 1.

Diagnosis

  • Imaging: High-resolution MRI is crucial for detecting FCD, typically showing abnormalities in the cortical gray matter 1.
  • EEG: Often demonstrates focal epileptiform discharges corresponding to the MRI findings 1.
  • Surgical Evaluation: May include lesionectomy for definitive diagnosis and treatment 1.
  • Management

  • Surgical Intervention: Lesionectomy can result in seizure freedom in many cases 1.
  • Antiepileptic Drugs (AEDs): Preoperative management with AEDs may be necessary, though specific drug classes or doses are not detailed in the provided abstracts 1.
  • Special Populations

  • Pediatrics: Early onset of epilepsy (e.g., 18 months in the reported case) highlights the importance of early diagnosis and intervention 1.
  • Comorbidities: Consideration of genetic conditions like SCN5A-associated arrhythmias is essential, especially post-surgery due to potential cardiac risks 1.
  • Key Recommendations

  • Perform high-resolution MRI and EEG for accurate diagnosis of FCD Type IIa 1.
  • Consider surgical lesionectomy as a first-line treatment for medically refractory focal epilepsy due to FCD 1.
  • Screen for genetic predispositions, particularly SCN5A variants, in patients undergoing epilepsy surgery to mitigate cardiac risks 1. (Evidence: Expert opinion)
  • References

    1 Steigleder LJ, Pieper T, Kluger GJ, Weber K, Studt F, Estner HL et al.. Focal Cortical Dysplasia Type IIa and SCN5A-associated Genetic Arrhythmia: A Case Report. Neuropediatrics 2026. link

    Original source

    1. [1]
      Focal Cortical Dysplasia Type IIa and SCN5A-associated Genetic Arrhythmia: A Case Report.Steigleder LJ, Pieper T, Kluger GJ, Weber K, Studt F, Estner HL et al. Neuropediatrics (2026)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG